Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa may be a type of autoinflammatory skin disease linked to gene mutations and immune system issues.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

The gut microbiome affects the development of alopecia areata.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Matrix changes and increased MMPs contribute to skin inflammation in hidradenitis suppurativa.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Many patients with Alopecia Areata have underlying autoimmune disorders, especially thyroid issues.

Upadacitinib improved multiple immune-related conditions in one patient.

Microbes might play a role in vitiligo.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

SQSTM1 is linked to increased risk of alopecia areata.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

A woman with lupus had blood cell destruction, treated successfully with medication.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.